Center Profile

Share QR code Edit Profile

Center for Drug Evaluation and Safety (CoDES)

Director:

Almut Winterstein

Distinguished Professor, Director For Codes, Director For Consortium For Medical Marijuana Clinical Outcomes Research

3522736258

almut@cop.ufl.edu

View:

Select
All (all in one) Mission Funded Research Websites Contact

All
Mission
Funded Research
Websites
Contact

Mission

The UF Center for Drug Evaluation and Safety unites researchers interested in using big data to evaluate drugs and the safety of medications in real-world populations.

DCU Number: 10.2840

Research Terms

Pharmaceutics Pharmacology

Funded Research

These projects reflect the research conducted by the center experts.

End

Title

06-2025

Precision antiplatelet therapy after percutaneous corona Precision antiplatelet therapy after percutaneous corona

01-2024

Application of physiologically-based pharmacokinetic models to inform dosing recommendations for hormonal contraceptives co-administered with other medications Application of physiologically-based pharmacokinetic models to inform dosing recommendations for hormonal contraceptives co-administered with other medications

08-2023

Medical Literature and Data on Cannabis Use Medical Literature and Data on Cannabis Use

07-2023

Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma (MATCH) Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma (MATCH)

06-2023

Advancing Personalized Hypertension Care through Big Data Science Advancing Personalized Hypertension Care through Big Data Science

04-2023

Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations

12-2022

Sentinel 2014: TreeScan in Pregnancy # Maternal Outcomes Sentinel 2014: TreeScan in Pregnancy # Maternal Outcomes

12-2022

Merck Graduate Program Work Plan #2 Merck Graduate Program Work Plan #2

10-2022

Preventing the Calcium Channel Blocker # Lower Extremity Edema # Loop Diuretic Prescribing Cascade in Older Adults Preventing the Calcium Channel Blocker # Lower Extremity Edema # Loop Diuretic Prescribing Cascade in Older Adults

09-2022

Epidemiology and cost of RSV infections in infants and toddlers Epidemiology and cost of RSV infections in infants and toddlers

05-2022

Pharmacological Management of Pain in Alzheimer's Disease and Related Dementia Pharmacological Management of Pain in Alzheimer's Disease and Related Dementia

01-2022

Developing a Real-Time Trajectory Tool to Identify Potentially Unsafe Concurrent Opioid and Benzodiazepine Use among Older Adults Developing a Real-Time Trajectory Tool to Identify Potentially Unsafe Concurrent Opioid and Benzodiazepine Use among Older Adults

12-2021

BD&L Discovery Transactions Work Plan BD&L Discovery Transactions Work Plan

06-2021

Together: Transforming and Translating Discovery to Improve Health Together: Transforming and Translating Discovery to Improve Health

03-2021

Safety of Gadolinium-Enhanced MRI Exposure During Pregnancy on Adverse Fetal Outcomes Safety of Gadolinium-Enhanced MRI Exposure During Pregnancy on Adverse Fetal Outcomes

03-2021

Task Order: Developing the Capability of Using National Medicaid data for FDA Post-Marketing Surveillance to Assess Medication Safety During Pregnancy Task Order: Developing the Capability of Using National Medicaid data for FDA Post-Marketing Surveillance to Assess Medication Safety During Pregnancy

12-2020

Consortium for Medical Marijuana Clinical Outcomes Research Consortium for Medical Marijuana Clinical Outcomes Research

09-2020

The Child Health Quality (CHeQ) Partnership Program The Child Health Quality (CHeQ) Partnership Program

09-2019

Observational External Comparator Cohorts as Controls for Long-Term Uncontrolled Extensions to RCTs Observational External Comparator Cohorts as Controls for Long-Term Uncontrolled Extensions to RCTs

02-2019

Inpatient Psychiatric Facility Outcome & Process Amendment 2 - Year 5 Option Year 4 (September 30, 2018 to February 15, 2019) Inpatient Psychiatric Facility Outcome & Process Amendment 2 - Year 5 Option Year 4 (September 30, 2018 to February 15, 2019)

09-2018

HHSM-500-2013-13007I, Task Order # HHSM-500-T0004, Inpatient Psychiatric Facility Outcome and Process Measure Development & Maintenance_Task 2.1 HHSM-500-2013-13007I, Task Order # HHSM-500-T0004, Inpatient Psychiatric Facility Outcome and Process Measure Development & Maintenance_Task 2.1

01-2018

Real-time risk stratification for hypo- or hyperglycemia Real-time risk stratification for hypo- or hyperglycemia

09-2017

inpatient psychiatric facility outcome & process measure inpatient psychiatric facility outcome & process measure

02-2017

TRAVEL REIMBURSEMENT AGREEMENT TRAVEL REIMBURSEMENT AGREEMENT

01-2017

evaluating changes in order sets for impatient pain evaluating changes in order sets for impatient pain

06-2016

Development and Validation of a Complexity Score to Iden Development and Validation of a Complexity Score to Iden

09-2015

MIDS-141193: Inpatient Psychiatric Facility Outcome & Process Measure Development and Maintenance MIDS-141193: Inpatient Psychiatric Facility Outcome & Process Measure Development and Maintenance

06-2015

FL Ctr for Medicaid and the Uninsured Contract: Prj 1-8 FL Ctr for Medicaid and the Uninsured Contract: Prj 1-8

07-2014

Pre-existing Diabetes and Pregnancy Pre-existing Diabetes and Pregnancy

07-2014

Maintenance and Development of Medication Measures Maintenance and Development of Medication Measures

07-2014

Agreement: Florida Medical Quality Assurance and UF Agreement: Florida Medical Quality Assurance and UF

09-2013

Scalable PArtnering Network for CER: Across Lifespan, Co Scalable PArtnering Network for CER: Across Lifespan, Co

08-2013

Type II Diabetes in Pregnant Women: Prevalence, Drug Type II Diabetes in Pregnant Women: Prevalence, Drug

01-2013

Prevalence and Incidence of Nontuberculous Mycobacteria Prevalence and Incidence of Nontuberculous Mycobacteria

09-2012

Comparative Safety and Effectiveness of Stimulants in Comparative Safety and Effectiveness of Stimulants in

08-2012

Developing Evidence to Inform Decisions about Effectiven Developing Evidence to Inform Decisions about Effectiven

08-2012

2011 AFPE predoc fellowship 2011 AFPE predoc fellowship

07-2012

POP Training Program for Health Science Grad Cohort 2 POP Training Program for Health Science Grad Cohort 2

07-2011

POP Training Program for Health Science Graduates Cohort POP Training Program for Health Science Graduates Cohort

05-2011

Effectiveness of Palivizumab Immoprophylaxis in Children Effectiveness of Palivizumab Immoprophylaxis in Children

04-2010

Risk Factors for Intraoperative Vasoplegia and Post- Risk Factors for Intraoperative Vasoplegia and Post-

03-2009

Consumer Medication Information Evaluation Project 2007 Consumer Medication Information Evaluation Project 2007

12-2007

PROPHYLACTIC USE OF NESIRITIDE (Brain Natriuretic Peptid PROPHYLACTIC USE OF NESIRITIDE (Brain Natriuretic Peptid

12-2006

Evaluation of Florida Medicaid Programs for FY 2005 Evaluation of Florida Medicaid Programs for FY 2005

09-2004

NATURE and ETIOLOGY OF MEDICATION ERRORS OF OMISSION-CREAT NATURE and ETIOLOGY OF MEDICATION ERRORS OF OMISSION-CREAT

06-2004

DEVELOPMENT OF A SCREENING INSTRUMENT FOR PREVENTABLE DR DEVELOPMENT OF A SCREENING INSTRUMENT FOR PREVENTABLE DR

10-2003

DEVELOPMENT OF A SCREENING TOOL FOR MEDICATION ERRORS IN DEVELOPMENT OF A SCREENING TOOL FOR MEDICATION ERRORS IN

Websites

https://codes.pharmacy.ufl.edu/

Directors

Almut Winterstein

Distinguished Professor, Director For Codes, Director For Consortium For Medical Marijuana Clinical Outcomes Research

3522736258

almut@cop.ufl.edu

Call Email

Contact Information

Director

almut@cop.ufl.edu

3522736258

Center

College of Pharmacy
1225 Center Dr.
Gainesville, FL 32610

(352) 273-6581

Profile QR code

What is this?

Center for Drug Evaluation and Safety (CoDES)

Mission

Research Terms

Funded Research

Websites

Directors

Contact Information

About

Discover

Connect

Keyword Search

Browse by STEM